Madrigal Pharmaceuticals

(NASDAQ) MDGL

Current Price$497.16

Market Cap$11.46B

Since IPO (2016)+4,799%

5 Year+343%

1 Year+84%

1 Month-4%

Madrigal Pharmaceuticals Financials at a Glance

Market Cap

$11.46B

Revenue (TTM)

$1.13B

Net Income (TTM)

-$309.44M

EPS (TTM)

-$12.80

P/E Ratio

-38.85

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$497.16

Volume

436,007

Open

$514.57

Price

$497.16

Volume

436,007

Open

$514.57

Previous Close

$497.27

Daily Range

$496.63 - $520.31

52-Week Range

$268.69 - $615.00

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$497.16

Volume

436,007

Open

$514.57

Previous Close

$497.27

Daily Range

$496.63 - $520.31

52-Week Range

$268.69 - $615.00

MDGL News

A scientist looking through a microscope.

Page 1

MDGL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Madrigal Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

915

CEO

William J. Sibold, MBA

Website

www.madrigalpharma.com

Headquarters

West Conshohocken, PA 19428, US

MDGL Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

-28%

Net Income Margin

-27%

Return on Equity

-49%

Return on Capital

-35%

Return on Assets

-25%

Earnings Yield

-2.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.46B

Shares Outstanding

23.06M

Volume

436.01K

Avg. Volume

315.68K

Financials (TTM)

Gross Profit

$902.26M

Operating Income

-$300.10M

EBITDA

-$264.47M

Operating Cash Flow

-$189.55M

Capital Expenditure

-$467.00K

Free Cash Flow

-$190.02M

Cash & ST Invst.

$983.56M

Total Debt

$354.36M

Madrigal Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$311.34M

+126.8%

Gross Profit

$284.49M

+114.3%

Gross Margin

91.38%

N/A

Market Cap

$11.46B

N/A

Market Cap/Employee

$21.71M

N/A

Employees

528

N/A

Net Income

-$94.39M

-28.9%

EBITDA

-$92.72M

-33.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$470.62M

-34.9%

Accounts Receivable

$187.36M

+205.0%

Inventory

$112.07M

+102.9%

Long Term Debt

$345.61M

+191.0%

Short Term Debt

$1.70M

+67.0%

Return on Assets

-25.21%

N/A

Return on Invested Capital

-35.26%

N/A

Free Cash Flow

-$171.28M

-92.7%

Operating Cash Flow

-$167.44M

-88.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BMRNBioMarin Pharmaceutical Inc.

BMRNBioMarin Pharmaceutical Inc.$57.29+8.63%

EXELExelixis, Inc.

EXELExelixis, Inc.$50.48-1.89%

BAXBaxter International Inc.

BAXBaxter International Inc.$18.78-2.44%

ABVXAbivax S.A.

ABVXAbivax S.A.$132.63+2.42%

JAZZJazz Pharmaceuticals plc

JAZZJazz Pharmaceuticals plc$236.49+0.47%

TECHBio-Techne Corporation

TECHBio-Techne Corporation$51.68+1.65%

RYTMRhythm Pharmaceuticals, Inc.

RYTMRhythm Pharmaceuticals, Inc.$88.32-5.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$114.68-0.05%

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

FFord Motor Company

FFord Motor Company$17.44+0.05%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

SMCISuper Micro Computer

SMCISuper Micro Computer$46.09+0.12%

PLTRPalantir Technologies

PLTRPalantir Technologies$156.54+0.09%

Questions About MDGL

What is the current price of Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals is trading at $497.27 per share.

What is the 52-week range for Madrigal Pharmaceuticals?

Over the past 52 weeks, Madrigal Pharmaceuticals has traded between $268.69 and $615.00.

How much debt does Madrigal Pharmaceuticals have?

As of the most recent reporting period, Madrigal Pharmaceuticals reported total debt of $347.31M.

How much cash does Madrigal Pharmaceuticals have on hand?

Madrigal Pharmaceuticals reported $232.19M in cash and cash equivalents in its most recent financial results.

What is Madrigal Pharmaceuticals’s dividend yield?

Madrigal Pharmaceuticals does not currently have a dividend yield.

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals Financials at a Glance

MDGL News

Best Biotech ETFs to Buy in 2026

How to Invest in SPDR S&P Biotech ETF (XBI)

Biotech vs. Pharma: What's the Difference?

Why Madrigal Pharmaceuticals Stock Slumped on Tuesday

Madrigal (MDGL) Q2 Revenue Soars 1,313%

Why Madrigal Pharmaceuticals Stock Is Soaring Today

Why Madrigal Pharmaceuticals Stock Was Plummeting This Week

Why Madrigal Pharmaceuticals Stock Is Sinking Today

MDGL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Madrigal Pharmaceuticals

MDGL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Madrigal Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MDGL

What is the current price of Madrigal Pharmaceuticals?

What is the 52-week range for Madrigal Pharmaceuticals?

How much debt does Madrigal Pharmaceuticals have?

How much cash does Madrigal Pharmaceuticals have on hand?

What is Madrigal Pharmaceuticals’s dividend yield?

Premium Investing Services